Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Submitted by
admin
on September 17, 2016 - 1:16pm
Source:
Yahoo/Reuters
News Tags:
Novo Nordisk
semaglutide
diabetes
Headline:
Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent
Do Not Allow Advertisers to Use My Personal information
